Aware for All, the Clinical Research Education Awareness Day, is May 21
On Saturday, May 21, in Boston Massachusetts, the newly formed non-profit organization -- CISCRP -- will be hosting an event called Aware for All to help educate the public about the clinical research process and the role that it plays in public health.
On Saturday, May 21, in Boston Massachusetts, the newly formed non-profit organization -- CISCRP -- will be hosting an event called Aware for All to help educate the public about the clinical research process and the role that it plays in public health. This is the first event ever of its kind to be held nationally -- and globally.
Aware for All's Honorary Co-Chairs are Lt. Governor Kerry Healey and Boston Mayor Thomas Menino. Featured speakers at the event include Dr. Bernard Schwetz, director US Office for Human Research Protections, Dr. Judy Bigby, Brigham & Women's Hospital, Dr. Karen Freund, Boston Medical Center, Dr. Patricia Hibberd, Tufts-New England Medical Center, and Dr. George Demitri, Dana Farber Cancer Institute to name a few.
For more information, visit www.ciscrp.org
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
